<p>直觉外科（NASDAQ:ISRG - 获取免费报告）于周四公布了其财报。该医疗设备供应商报告本季度每股收益为 2.53 美元，超出分析师一致预期的 2.25 美元，超出幅度为 0.28 美元，FiscalAI 报道。直觉外科的净利润率为 28.58%，股本回报率为 15.08%。该公司本季度的收入为 28.7 亿美元，而分析师的预期为 27.2 亿美元。</p>
<p>获取 <strong>Intuitive Surgical</strong> 的提醒：</p>
<h2>直觉外科股票上涨 0.3%</h2>
<ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股</li>
</ul>
<p>直觉外科的股票在周四交易中上涨了 1.63 美元，达到 525.32 美元。该公司交易了 2,167,893 股，较其平均交易量 2,008,178 股有所增加。直觉外科的 52 周低点为 425.00 美元，52 周高点为 616.00 美元。该公司的 50 日移动平均价格为 563.63 美元，200 日移动平均价格为 511.76 美元。该股票的市值为 1883.2 亿美元，市盈率为 69.49，市盈增长比率为 4.28，贝塔值为 1.67。</p>
<h2>直觉外科内部活动</h2>
<p>在相关消息中，执行副总裁亨利·L·查尔顿于 11 月 12 日（星期三）出售了 13,731 股公司的股票。股票以 580.00 美元的平均价格出售，总交易额为 7,963,980.00 美元。交易后，该执行副总裁持有 3,056 股公司的股票，价值约为 1,772,480 美元。这代表其持股比例减少了 81.80%。该出售在向 SEC 的备案中披露，相关信息可在 SEC 网站上查阅。此外，首席执行官大卫·J·罗萨于 10 月 24 日（星期五）出售了 24,500 股股票，股票以 547.55 美元的平均价格出售，总价值为 13,414,975.00 美元。交易后，首席执行官在公司中持有 234,256 股，价值为 128,266,872.80 美元。此交易代表其持股比例减少了 9.47%。有关此出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士共出售了 114,007 股公司股票，价值为 63,533,844 美元。内部人士持有该股票的比例为 0.70%。</p>
<h2>机构投资者对直觉外科的看法</h2>
<ul>
<li>2 只医疗股可能因财报获得大幅提振</li>
</ul>
<p>一些机构投资者最近增加或减少了对该公司的持股。Riggs Asset Managment Co. Inc.在第二季度将其在直觉外科的持股增加了 84.2%。Riggs Asset Managment Co. Inc.目前持有 70 股该医疗设备供应商的股票，价值 38,000 美元，此前在上个季度又购买了 32 股。JPL Wealth Management LLC 在第三季度购买了直觉外科的新头寸，价值约为 45,000 美元。Wealth Watch Advisors INC 在第三季度获得了直觉外科的新头寸，价值约为 52,000 美元。Triumph Capital Management 在第三季度购买了直觉外科的新股份，价值约为 54,000 美元。最后，Measured Wealth Private Client Group LLC 在第三季度获得了直觉外科的股份，价值 70,000 美元。对冲基金和其他机构投资者持有该公司 83.64% 的股票。</p>
<h2>直觉外科新闻摘要</h2>
<p>以下是本周影响直觉外科的主要新闻：</p>
<ul>
<li>积极情绪：美国银行启动覆盖，给予买入评级，为投资者提供了新的、可信的买方背书，可能提升近期对该股票的需求。直觉外科（ISRG）获得美国银行证券的买入评级</li>
<li>积极情绪：市场轮动进入医疗科技，乐观的行业论点突显 ISRG 的经常性收入模式和手术增长，支持多年的增长案例和分析师的目标价格高于当前股价。超越生物技术——3 只适合成长型投资者的医疗股（直觉外科部分）</li>
<li>积极情绪：长期乐观分析认为，ISRG 的机器人驱动增长和刀片与刀柄的经常性收入在多年的时间范围内创造了吸引人的上行空间，强化了成长投资者的买入和持有叙事。直觉外科在五年后会在哪里？</li>
<li>中性情绪：多份财报预览和分析师笔记（TipRanks、MSN、Zacks）强调第四季度的业绩和指引是下一个催化剂；这些预览突出了投资者应关注的指标（手术量、系统部署、经常性消耗品增长）。直觉外科（ISRG）即将公布第四季度财报。以下是预期</li>
<li>中性情绪：关于每周失业救济申请的宏观头条消息喜忧参半，可能影响广泛市场的风险偏好（从而影响医疗科技的倍数扩张/收缩），但并不会直接改变 ISRG 的基本面。失业救济申请保持在 20 万以上，第三季度 GDP 增长至 4.4%</li>
<li>消极情绪：短期技术疲软：覆盖笔记和市场报告指出，该股票已延续了亏损趋势，这可能触发止损和短期卖压，即使基本面保持不变。直觉外科连续七个交易日亏损</li>
<li>消极情绪：估值争论：评论质疑 ISRG 在近期价格表现疲软后是否被高估，可能使一些投资者在更清晰的财报/指引证据出现之前保持观望。评估直觉外科（ISRG）股票在近期价格表现疲软后是否显得被高估</li>
</ul>
<h2>华尔街分析师的看法</h2>
<ul>
<li>1.34 亿美元的内部交易：这可能对 KMI、ISRG 和 QS 意味着什么</li>
</ul>
<p>最近，一些研究分析师对该公司发布了报告。Weiss Ratings 在 12 月 29 日的报告中重新发布了对 Intuitive Surgical 股票的 “持有（c+）” 评级。高盛集团在 1 月 9 日的研究报告中重新发布了 “买入” 评级，并对 Intuitive Surgical 股票设定了 714.00 美元的目标价。Raymond James Financial 在 10 月 22 日的研究报告中对 Intuitive Surgical 股票设定了 603.00 美元的目标价，并给予该股票 “跑赢大盘” 的评级。瑞银集团在 1 月 15 日的研究报告中重申了对 Intuitive Surgical 股票的 “中性” 评级。最后，Truist Financial 在 12 月 18 日的研究报告中将 Intuitive Surgical 股票的目标价从 620.00 美元上调至 650.00 美元，并给予该股票 “买入” 评级。有两位研究分析师给予该股票 “强烈买入” 评级，十六位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标价为 622.17 美元。</p>
<p><strong>查看我们对 Intuitive Surgical 的最新分析</strong></p>
<h2>Intuitive Surgical 公司简介</h2>
<p>(获取免费报告)</p>
<p>Intuitive Surgical 成立于 1995 年，总部位于加利福尼亚州阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗技术公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。Intuitive 的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室的精确度、可视化和控制能力。</p>
<p>除了其核心手术平台外，Intuitive 还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Intuitive Surgical</li>
<li>特朗普的 AI 秘密：比 Nvidia 快 100 倍</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
<li>新的黄金价格目标</li>
<li>没有人告诉你的 100 万亿美元 AI 故事</li>
<li>特朗普做了什么？？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Intuitive Surgical 吗？</h2>
<p>在考虑投资 Intuitive Surgical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Intuitive Surgical 并不在名单上。</p>
<p>虽然 Intuitive Surgical 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

标普健康医疗设备 ETF - SPDR

ISUL

直觉外科

美国医药设备 ETF - iShares

<p>直觉外科 (NASDAQ:ISRG) 报告每股收益为 2.53 美元，超出预期的 2.25 美元，季度收入为 28.7 亿美元，超过预期的 27.2 亿美元。该公司实现净利润率为 28.58%，股本回报率为 15.08%。公告发布后，股价上涨 0.3%，至 525.32 美元。内部交易中高管进行了大量出售，机构投资者持有 83.64% 的股份。分析师们保持乐观，摩根大通首次覆盖给予买入评级，强调医疗科技领域的增长潜力</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) announced its earnings results on Thursday. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts' consensus estimates of $2.25 by $0.28, FiscalAI reports. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）于周四公布了其财报。该医疗设备供应商报告本季度每股收益为 2.53 美元，超出分析师一致预期的 2.25 美元，超出幅度为 0.28 美元，FiscalAI 报道。直觉外科的净利润率为 28.58%，股本回报率为 15.08%。该公司本季度的收入为 28.7 亿美元，而分析师的预期为 27.2 亿美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 的提醒：</p>
</div><h2>Intuitive Surgical Stock Up 0.3%</h2>
<div class="lb-trans"><h2>直觉外科股票上涨 0.3%</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股</li>
</ul>
</div><p>Shares of Intuitive Surgical stock traded up $1.63 during trading on Thursday, hitting $525.32. 2,167,893 shares of the company were exchanged, compared to its average volume of 2,008,178. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a 50 day moving average price of $563.63 and a 200 day moving average price of $511.76. The stock has a market capitalization of $188.32 billion, a price-to-earnings ratio of 69.49, a P/E/G ratio of 4.28 and a beta of 1.67.</p>
<div class="lb-trans"><p>直觉外科的股票在周四交易中上涨了 1.63 美元，达到 525.32 美元。该公司交易了 2,167,893 股，较其平均交易量 2,008,178 股有所增加。直觉外科的 52 周低点为 425.00 美元，52 周高点为 616.00 美元。该公司的 50 日移动平均价格为 563.63 美元，200 日移动平均价格为 511.76 美元。该股票的市值为 1883.2 亿美元，市盈率为 69.49，市盈增长比率为 4.28，贝塔值为 1.67。</p>
</div><h2>Insider Activity at Intuitive Surgical</h2>
<div class="lb-trans"><h2>直觉外科内部活动</h2>
</div><p>In related news, EVP Henry L. Charlton sold 13,731 shares of the company's stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares of the company's stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 in the last ninety days. 0.70% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁亨利·L·查尔顿于 11 月 12 日（星期三）出售了 13,731 股公司的股票。股票以 580.00 美元的平均价格出售，总交易额为 7,963,980.00 美元。交易后，该执行副总裁持有 3,056 股公司的股票，价值约为 1,772,480 美元。这代表其持股比例减少了 81.80%。该出售在向 SEC 的备案中披露，相关信息可在 SEC 网站上查阅。此外，首席执行官大卫·J·罗萨于 10 月 24 日（星期五）出售了 24,500 股股票，股票以 547.55 美元的平均价格出售，总价值为 13,414,975.00 美元。交易后，首席执行官在公司中持有 234,256 股，价值为 128,266,872.80 美元。此交易代表其持股比例减少了 9.47%。有关此出售的更多细节可在官方 SEC 披露中找到。在过去 90 天内，内部人士共出售了 114,007 股公司股票，价值为 63,533,844 美元。内部人士持有该股票的比例为 0.70%。</p>
</div><h2>Institutional Investors Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>机构投资者对直觉外科的看法</h2>
</div><ul>
<li>2 Healthcare Names That Could Get a Big Boost From Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只医疗股可能因财报获得大幅提振</li>
</ul>
</div><p>A number of institutional investors have recently added to or reduced their stakes in the company. Riggs Asset Managment Co. Inc. lifted its stake in shares of Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider's stock valued at $38,000 after purchasing an additional 32 shares in the last quarter. JPL Wealth Management LLC purchased a new position in Intuitive Surgical in the third quarter valued at approximately $45,000. Wealth Watch Advisors INC acquired a new position in Intuitive Surgical during the third quarter valued at approximately $52,000. Triumph Capital Management purchased a new stake in Intuitive Surgical during the third quarter worth approximately $54,000. Finally, Measured Wealth Private Client Group LLC acquired a new stake in shares of Intuitive Surgical in the third quarter worth $70,000. Hedge funds and other institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者最近增加或减少了对该公司的持股。Riggs Asset Managment Co. Inc.在第二季度将其在直觉外科的持股增加了 84.2%。Riggs Asset Managment Co. Inc.目前持有 70 股该医疗设备供应商的股票，价值 38,000 美元，此前在上个季度又购买了 32 股。JPL Wealth Management LLC 在第三季度购买了直觉外科的新头寸，价值约为 45,000 美元。Wealth Watch Advisors INC 在第三季度获得了直觉外科的新头寸，价值约为 52,000 美元。Triumph Capital Management 在第三季度购买了直觉外科的新股份，价值约为 54,000 美元。最后，Measured Wealth Private Client Group LLC 在第三季度获得了直觉外科的股份，价值 70,000 美元。对冲基金和其他机构投资者持有该公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical News Summary</h2>
<div class="lb-trans"><h2>直觉外科新闻摘要</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本周影响直觉外科的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Bank of America initiated coverage with a Buy, giving investors a fresh, reputable buy-side endorsement that can lift near-term demand for the shares. Intuitive Surgical (ISRG) Receives a Buy from Bank of America Securities</li>
<li>Positive Sentiment: Market rotation into medtech and a bullish sector thesis highlight ISRG’s recurring-revenue model and procedure growth, supporting a multi-year growth case and analyst price targets above the current share price. Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors (Intuitive Surgical section)</li>
<li>Positive Sentiment: Long-term bullish analysis argues ISRG’s robotics-led growth and razor‑and‑blade recurring revenue create attractive upside over a multi-year horizon, reinforcing buy-and-hold narratives for growth investors. Where Will Intuitive Surgical Be in 5 Years?</li>
<li>Neutral Sentiment: Multiple earnings previews and analyst notes (TipRanks, MSN, Zacks) emphasize Q4 results and guidance as the next catalyst; these previews highlight metrics investors should watch (procedure volumes, system placements, recurring consumable growth). Intuitive Surgical (ISRG) Is About to Report Q4 Earnings. Here Is What to Expect</li>
<li>Neutral Sentiment: Macro headlines on weekly jobless claims are mixed and may influence broad market risk appetite (and thus medtech multiple expansion/contraction), but they don’t directly alter ISRG’s fundamentals. Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%</li>
<li>Negative Sentiment: Short-term technical weakness: coverage notes and market reports point out the stock has been extending a losing streak, which can trigger stop-losses and short-term selling pressure even if fundamentals remain intact. Intuitive Surgical continues losses for seven straight sessions</li>
<li>Negative Sentiment: Valuation debate: commentary questioning whether ISRG is overvalued after recent weak price performance could keep some investors sidelined until clearer earnings/guidance evidence appears. Assessing Whether Intuitive Surgical (ISRG) Shares Look Overvalued After Recent Weak Price Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：美国银行启动覆盖，给予买入评级，为投资者提供了新的、可信的买方背书，可能提升近期对该股票的需求。直觉外科（ISRG）获得美国银行证券的买入评级</li>
<li>积极情绪：市场轮动进入医疗科技，乐观的行业论点突显 ISRG 的经常性收入模式和手术增长，支持多年的增长案例和分析师的目标价格高于当前股价。超越生物技术——3 只适合成长型投资者的医疗股（直觉外科部分）</li>
<li>积极情绪：长期乐观分析认为，ISRG 的机器人驱动增长和刀片与刀柄的经常性收入在多年的时间范围内创造了吸引人的上行空间，强化了成长投资者的买入和持有叙事。直觉外科在五年后会在哪里？</li>
<li>中性情绪：多份财报预览和分析师笔记（TipRanks、MSN、Zacks）强调第四季度的业绩和指引是下一个催化剂；这些预览突出了投资者应关注的指标（手术量、系统部署、经常性消耗品增长）。直觉外科（ISRG）即将公布第四季度财报。以下是预期</li>
<li>中性情绪：关于每周失业救济申请的宏观头条消息喜忧参半，可能影响广泛市场的风险偏好（从而影响医疗科技的倍数扩张/收缩），但并不会直接改变 ISRG 的基本面。失业救济申请保持在 20 万以上，第三季度 GDP 增长至 4.4%</li>
<li>消极情绪：短期技术疲软：覆盖笔记和市场报告指出，该股票已延续了亏损趋势，这可能触发止损和短期卖压，即使基本面保持不变。直觉外科连续七个交易日亏损</li>
<li>消极情绪：估值争论：评论质疑 ISRG 在近期价格表现疲软后是否被高估，可能使一些投资者在更清晰的财报/指引证据出现之前保持观望。评估直觉外科（ISRG）股票在近期价格表现疲软后是否显得被高估</li>
</ul>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师的看法</h2>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 亿美元的内部交易：这可能对 KMI、ISRG 和 QS 意味着什么</li>
</ul>
</div><p>A number of research analysts have recently issued reports on the company. Weiss Ratings reissued a &#34;hold (c+)&#34; rating on shares of Intuitive Surgical in a report on Monday, December 29th. The Goldman Sachs Group reissued a &#34;buy&#34; rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, October 22nd. UBS Group restated a &#34;neutral&#34; rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. Finally, Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, December 18th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $622.17.</p>
<div class="lb-trans"><p>最近，一些研究分析师对该公司发布了报告。Weiss Ratings 在 12 月 29 日的报告中重新发布了对 Intuitive Surgical 股票的 “持有（c+）” 评级。高盛集团在 1 月 9 日的研究报告中重新发布了 “买入” 评级，并对 Intuitive Surgical 股票设定了 714.00 美元的目标价。Raymond James Financial 在 10 月 22 日的研究报告中对 Intuitive Surgical 股票设定了 603.00 美元的目标价，并给予该股票 “跑赢大盘” 的评级。瑞银集团在 1 月 15 日的研究报告中重申了对 Intuitive Surgical 股票的 “中性” 评级。最后，Truist Financial 在 12 月 18 日的研究报告中将 Intuitive Surgical 股票的目标价从 620.00 美元上调至 650.00 美元，并给予该股票 “买入” 评级。有两位研究分析师给予该股票 “强烈买入” 评级，十六位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标价为 622.17 美元。</p>
</div><p><strong>View Our Latest Analysis on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Intuitive Surgical 的最新分析</strong></p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>Intuitive Surgical 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>Intuitive Surgical 成立于 1995 年，总部位于加利福尼亚州阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗技术公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。Intuitive 的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室的精确度、可视化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了其核心手术平台外，Intuitive 还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Trump’s AI Secret: 100X Faster Than Nvidia</li>
<li>Refund From 1933: Trump’s Reset May Create Instant Wealth</li>
<li>New gold price target</li>
<li>The $100 Trillion AI Story No One Is Telling You</li>
<li>Trump Did WHAT??</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Intuitive Surgical</li>
<li>特朗普的 AI 秘密：比 Nvidia 快 100 倍</li>
<li>1933 年的退款：特朗普的重置可能创造即时财富</li>
<li>新的黄金价格目标</li>
<li>没有人告诉你的 100 万亿美元 AI 故事</li>
<li>特朗普做了什么？？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Intuitive Surgical 吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 Intuitive Surgical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Intuitive Surgical 并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Intuitive Surgical 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

直觉外科（NASDAQ 代码：ISRG）公布了财报结果